Skip to main content
. 2019 Jul 24;41(2):237–248. doi: 10.1038/s41401-019-0275-z

Fig. 5.

Fig. 5

Amelioration of muscle atrophy and fat lipolysis under atractylenolide I treatment. a Results of a Western blot assay for MHC, Myogenin, MyoD, and MuRF-1 in gastrocnemius muscle tissues. b Quantitative analysis of the results from a. c Results of a Western blot assay for Perilipin, p-HSL, HSL, and UCP1 in eWAT. d Quantitative analysis of the results from c. Data presented are the mean ± SEM. *P < 0.05 versus healthy control group; #P < 0.05 versus spleen deficiency with cachexia group